| 5 | 1/1 | 返回列表 |
| 查看: 648 | 回復(fù): 2 | |||
| 當(dāng)前只顯示滿足指定條件的回帖,點(diǎn)擊這里查看本話題的所有回帖 | |||
letterman新蟲 (小有名氣)
|
[交流]
Postdoc position in Med Chem, McGill University, Canada
|
||
|
Position: Postdoctoral fellow in Medicinal Chemistry, under the supervision of Dr. Jian Hui Wu, Lady Davis Institute, McGill University, Montreal, Canada. Project description: Our laboratory is interested in identification and optimization of novel inhibitors against cancer targets. As a key member of our team, the candidate is expected to chemically optimize the initial active compounds. We routinely utilize structure-based approaches to identify top-ranking analogues to be synthesized. Our laboratory includes three components: structure-based drug design, Medicinal chemistry and biological evaluations. The funded projects are as follows: 1) Postdoc position 1: The start time is OCT, 2020. This funded project is to develop novel inhibitors of RanGTPase for ovarian cancer. Our preliminary work has discovered initial hits as novel inhibitors of RanGTPase, which are selectively active against the ovarian cancer cells, with no obvious effects on normal cells. 2) Postdoc position 2: The start time is NOV, 2020. This funded project is to develop novel modulators of Keap1/Nrf2 protein-protein interaction for lung cancer. Keap1 is an endogenous inhibitor of Nrf2. In normal cells, complexation of Keap1 with Nrf2 lead to Nrf2 degradation, resulting in basal level of Nrf2. However, mutation in Keap1 leads to Keap1 mutant that is unable to form a complex with Nrf2, resulting in high level of Nrf2 in cancer cells, which confer drug resistance in cancer patients. Our project is to discover compounds that could repair the interaction of Keap1 mutant with Nrf2, with a view to selectively suppressing Nrf2 level in cancer cells, which subsequently sensitize cancer cells to cancer treatment. We have already discovered initial hits that are selectively active against the Keap1 mutants, which are found in cancer cells, but have no effect on the wild-type Keap1, that are found in normal cells. Qualifications: We are looking for someone who is interested in anticancer drug discovery. The candidate should have a Ph.D. degree in Organic Chemistry/Medicinal Chemistry, which was obtained in 2018 or later. Language required: English Contact: Interested individuals should send a cover letter, CV and the coordinates of 2-3 referees to Dr. Jian Hui Wu (email address: Jian.H.Wu@McGill.CA). |
新蟲 (小有名氣)
銀蟲 (著名寫手)

| 最具人氣熱帖推薦 [查看全部] | 作者 | 回/看 | 最后發(fā)表 | |
|---|---|---|---|---|
|
[考研] 290求調(diào)劑 +4 | ADT 2026-03-11 | 4/200 |
|
|---|---|---|---|---|
|
[考研] 工科0856專碩化學(xué)工程269能調(diào)劑嗎 +9 | 我想讀研11 2026-03-10 | 9/450 |
|
|
[考研] 274求調(diào)劑0856材料化工 +8 | z2839474511 2026-03-11 | 8/400 |
|
|
[考研] 材料工程085601調(diào)劑求老師收留 +8 | 強(qiáng)木木木 2026-03-07 | 10/500 |
|
|
[考研] 求調(diào)劑 +4 | 鶴遨予卿 2026-03-09 | 4/200 |
|
|
[考研] 材料專碩288分求調(diào)劑 一志愿211 +3 | 在家想你 2026-03-11 | 3/150 |
|
|
[考研] 304求調(diào)劑(085602一志愿985) +8 | 化工人999 2026-03-09 | 8/400 |
|
|
[考研] 337一志愿華南理工材料求調(diào)劑 +5 | mysdl 2026-03-07 | 5/250 |
|
|
[考研] 復(fù)試調(diào)劑 +6 | 呼呼?~+123456 2026-03-08 | 8/400 |
|
|
[考博] 找博導(dǎo) +4 | 小呆呆熊 2026-03-07 | 4/200 |
|
|
[考研] 環(huán)境調(diào)劑 +5 | 曉看天暮看云 2026-03-09 | 5/250 |
|
|
[考研] 085600材料與化工,一志愿廣州985,求調(diào)劑 +15 | qqyyaill 2026-03-05 | 15/750 |
|
|
[考研] 考研調(diào)劑,一志愿山東大學(xué)材料與化工,328分,政治51 +5 | 關(guān)你西紅柿929 2026-03-08 | 6/300 |
|
|
[考研] 0703化學(xué)求調(diào)劑 +4 | 很老實(shí)人 2026-03-09 | 4/200 |
|
|
[考研] 求調(diào)劑,一志愿江南大學(xué),食品科學(xué)與工程,總分,320 +3 | yyyyyukino 2026-03-07 | 3/150 |
|
|
[教師之家] 交大前校長王樹國:現(xiàn)在最先進(jìn)的科技并不在大學(xué)實(shí)驗(yàn)室,而是在企業(yè)研究院 +4 | zju2000 2026-03-08 | 6/300 |
|
|
[考研] 347求調(diào)劑 +4 | 浮云滿足 2026-03-07 | 4/200 |
|
|
[考研] 誠求調(diào)劑,323分 有專利/科研/實(shí)習(xí)經(jīng)歷 +6 | 橙子cyx 2026-03-06 | 8/400 |
|
|
[考博] 2026年博士名額撿漏 +4 | 科研ya 2026-03-04 | 7/350 |
|
|
[考研] 275求調(diào)劑 +4 | 大爆炸難民 2026-03-06 | 5/250 |
|